Valendo Health

Valendo Health is a healthcare technology and services company dedicated to making specialty medications more accessible and affordable, including some of the most innovative treatments for cancer, autoimmune disease and other debilitating and life-threatening diseases. The company is on a mission to ensure neither logistical nor financial barriers interrupt a patient's treatment. Valendo Health has raised $14.5 million in Series A financing, led by BCM Bruker Capital Management GmbH with participation from RIKX Capital, A195 Capital, 49th Fund, James Watt, and Christoph Janz, to make specialty medications more accessible, coordinated, and affordable while enabling patients to receive treatment through care teams they know and trust.